Phathom Pharmaceuticals
Phathom Pharmaceuticals focuses on developing and commercializing new treatments for gastrointestinal diseases, with a strong emphasis on acid-related disorders such as GERD and H. pylori infection.
Services
Phathom Pharmaceuticals is focused on developing and commercializing new treatments for gastrointestinal (GI) diseases. The company supports a broad range of programs that offer support and resources to researchers, healthcare providers, patients, and their advocates. Phathom Pharmaceuticals considers funding initiatives in the therapeutic area of acid-related gastrointestinal disorders, focusing on Helicobacter pylori infection and Gastroesophageal Reflux Disease (GERD).
Clinical Trials and R&D
Phathom Pharmaceuticals has completed Phase 3 clinical trials for the treatment of Erosive GERD, Non-Erosive GERD, and H. pylori infection. The company plans to initiate an additional Phase 3 trial investigating a novel 'As Needed' dosing regimen for patients with Non-Erosive GERD. Phathom Pharmaceuticals is also advancing its development program across multiple acid-related GI disorders, including Non-Erosive GERD (NERD) and Eosinophilic Esophagitis (EoE). Late-stage clinical trials include the pHalcon-NERD Phase 2 On-demand (As Needed) trial and the pHalcon-NERD Phase 3 Daily Dosing trial.
Licensed Products
Phathom Pharmaceuticals holds the exclusive rights in the United States, Europe, and Canada to a potassium-competitive acid blocker (PCAB). The company's product VOQUEZNA® is available in the U.S. with prescribing information for both healthcare professionals and patients.
Employee Benefits
Phathom Pharmaceuticals offers a range of employee benefits, including highly competitive health coverage options with low monthly premiums, and a company-funded HSA plan. The company provides traditional and Roth 401(k) savings plans with an annual employer match, an employee stock equity program, and an employee stock purchase plan (ESPP). Additional benefits include comprehensive paid leave programs, an unlimited time off policy, short- and long-term disability benefits, professional development reimbursement, and an annual fitness and wellness reimbursement. Phathom Pharmaceuticals also offers voluntary pet insurance benefits.
Headquarters
Phathom Pharmaceuticals is headquartered in Florham Park, New Jersey, with its R&D headquarters located in Buffalo Grove, Illinois. The company's strategic locations support its commitment to developing and commercializing new treatments for gastrointestinal diseases.